These highlights do not include all the information needed to use GABAPENTIN CAPSULES safely and effectively. See full prescribing information for GABAPENTIN CAPSULES. GABAPENTIN capsules, for oral use Initial U.S. Approval: 1993

Set ID
4c22c3e6-2471-4b89-945b-f846c4d7884e
Manufacturer
Bryant Ranch Prepack
Effective date
2026-03-30
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 22:12:07

Key Label Information

Uses

1 INDICATIONS AND USAGE

Gabapentin capsules are indicated for: Management of postherpetic neuralgia in adults Adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy

4 CONTRAINDICATIONS

Gabapentin capsules are contraindicated in patients who have demonstrated hypersensitivity to the drug or its ingredients.

Warnings

4 CONTRAINDICATIONS

Gabapentin capsules are contraindicated in patients who have demonstrated hypersensitivity to the drug or its ingredients.

5 WARNINGS AND PRECAUTIONS

Directions And Dosage

2 DOSAGE AND ADMINISTRATION

3 DOSAGE FORMS AND STRENGTHS

Capsules : 100 mg: Opaque white cap and opaque white body imprinted with 'S617/100 mg' on cap with edible blue ink and strides logo on body with edible green ink. Filled with white to off white powder 300 mg: Opaque yellow cap and opaque yellow body imprinted with 'S618/300 mg' on cap with edible blue ink and strides logo on body with edible green ink. Filled with white to off white powder 400 mg: Opaque orange cap and opaque orange body imprinted with 'S619/400 mg' on cap with edible blue ink and strides logo on body with edible green ink. Filled with white to off white powder

10 OVERDOSAGE

Signs of acute toxicity in animals included ataxia, labored breathing, ptosis, sedation, hypoactivity, or excitation. Acute oral overdoses of gabapentin have been reported. Symptoms have included double vision, tremor, slurred speech, drowsiness, altered mental status, dizziness, lethargy, and diarrhea. Fatal respiratory depression has been reported with gabapentin overdose, alone and in combination with other CNS depressants. Gabapentin can be removed by hemodialysis. If overexposure occurs, call your poison control center at 1-800-222-1222.

Other Label Information

16 HOW SUPPLIED/STORAGE AND HANDLING

300 mg capsules: Opaque yellow cap and opaque yellow body imprinted with 'S618/300 mg' on cap with edible blue ink and strides logo on body with edible green ink. Filled with white to off white powder; available in: Bottles of 500: NDC 71335-3109-1 Store Gabapentin Capsules at 25°C (77°F); excursions permitted between 15°C to 30°C (59°F to 86°F) [See USP Controlled Room Temperature]. Dispense contents in a tight, light-resistant container as defined in the USP with a child-resistant closure; as required. KEEP CONTAINER TIGHTLY CLOSED KEEP THIS AND ALL MEDICATION OUT OF THE REACH OF CHILDREN. Repackaged/Relabeled by: Bryant Ranch Prepack Burbank, CA 91504

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Gabapentin 300mg Capsules

NDC Codes

Ingredients

NameUNIIKind
GABAPENTIN6CW7F3G59XACTIB
STARCH, CORNO8232NY3SJIACT
MANNITOL3OWL53L36AIACT
MAGNESIUM STEARATE70097M6I30IACT
TALC7SEV7J4R1UIACT
GELATIN, UNSPECIFIED2G86QN327LIACT
TITANIUM DIOXIDE15FIX9V2JPIACT
WATER059QF0KO0RIACT
FERRIC OXIDE YELLOWEX438O2MRTIACT
SHELLAC46N107B71OIACT
FD&C BLUE NO. 1H3R47K3TBDIACT
FD&C BLUE NO. 2L06K8R7DQKIACT

Complete SPL Sections

RECENT MAJOR CHANGES

RECENT MAJOR CHANGES SECTION

1 INDICATIONS AND USAGE

INDICATIONS & USAGE SECTION

Gabapentin capsules are indicated for: Management of postherpetic neuralgia in adults Adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy

2 DOSAGE AND ADMINISTRATION

DOSAGE & ADMINISTRATION SECTION

3 DOSAGE FORMS AND STRENGTHS

DOSAGE FORMS & STRENGTHS SECTION

Capsules : 100 mg: Opaque white cap and opaque white body imprinted with 'S617/100 mg' on cap with edible blue ink and strides logo on body with edible green ink. Filled with white to off white powder 300 mg: Opaque yellow cap and opaque yellow body imprinted with 'S618/300 mg' on cap with edible blue ink and strides logo on body with edible green ink. Filled with white to off white powder 400 mg: Opaque orange cap and opaque orange body imprinted with 'S619/400 mg' on cap with edible blue ink and strides logo on body with edible green ink. Filled with white to off white powder

4 CONTRAINDICATIONS

CONTRAINDICATIONS SECTION

Gabapentin capsules are contraindicated in patients who have demonstrated hypersensitivity to the drug or its ingredients.

5 WARNINGS AND PRECAUTIONS

WARNINGS AND PRECAUTIONS SECTION

6 ADVERSE REACTIONS

ADVERSE REACTIONS SECTION

The following serious adverse reactions are discussed in greater detail in other sections: Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)/Multiorgan Hypersensitivity [see Warnings and Precautions (5.1)] Anaphylaxis and Angioedema [see Warnings and Precautions (5.2)] Somnolence/Sedation and Dizziness [see Warnings and Precautions (5.4)] Suicidal Behavior and Ideation [see Warnings and Precautions (5.5)] Increased Risk of Seizures and Other Adverse Reactions with Abrupt or Rapid Discontinuation [see Warnings and Precautions (5.6)] Status Epilepticus [see Warnings and Precautions (5.7)] Respiratory Depression [see Warnings and Precautions (5.8)] Neuropsychiatric Adverse Reactions (Pediatric Patients 3 to 12 Years of Age) [see Warnings and Precautions (5.9)]

7 DRUG INTERACTIONS

DRUG INTERACTIONS SECTION

8 USE IN SPECIFIC POPULATIONS

USE IN SPECIFIC POPULATIONS SECTION

9 DRUG ABUSE AND DEPENDENCE

DRUG ABUSE AND DEPENDENCE SECTION

10 OVERDOSAGE

OVERDOSAGE SECTION

Signs of acute toxicity in animals included ataxia, labored breathing, ptosis, sedation, hypoactivity, or excitation. Acute oral overdoses of gabapentin have been reported. Symptoms have included double vision, tremor, slurred speech, drowsiness, altered mental status, dizziness, lethargy, and diarrhea. Fatal respiratory depression has been reported with gabapentin overdose, alone and in combination with other CNS depressants. Gabapentin can be removed by hemodialysis. If overexposure occurs, call your poison control center at 1-800-222-1222.

11 DESCRIPTION

DESCRIPTION SECTION

The active ingredient in gabapentin capsules USP is gabapentin, which has the chemical name 1-(aminomethyl)cyclohexaneacetic acid. The molecular formula of gabapentin is C 9 H 17 NO 2 and the molecular weight is 171.24. The structural formula of gabapentin is: Gabapentin, USP is a white to off-white crystalline powder with a pH of 6.5 – 7.5. It is freely soluble in water and sparingly soluble in methanol. Each gabapentin capsule contains 100 mg, 300mg or 400 mg of gabapentin and the following inactive ingredients: Corn starch, magnesium stearate, mannitol and talc. The 100mg capsule shell contains gelatin, titanium dioxide, and water. The 300mg capsule shell contains gelatin, iron oxide yellow, titanium dioxide and water. The 400mg capsule shell contains FD&C Blue #1, FD&C Yellow #6, gelatin, titanium dioxide and water. The imprinting ink Green Tek SB 4027 contains shellac, iron oxide yellow & FD & C Blue # 1 Aluminum Lake. The imprinting ink Blue Tek SB 6018 contains Shellac and FD & C Blue # 2 Aluminum Lake.

12 CLINICAL PHARMACOLOGY

CLINICAL PHARMACOLOGY SECTION

13 NONCLINICAL TOXICOLOGY

NONCLINICAL TOXICOLOGY SECTION

14 CLINICAL STUDIES

CLINICAL STUDIES SECTION

16 HOW SUPPLIED/STORAGE AND HANDLING

HOW SUPPLIED SECTION

300 mg capsules: Opaque yellow cap and opaque yellow body imprinted with 'S618/300 mg' on cap with edible blue ink and strides logo on body with edible green ink. Filled with white to off white powder; available in: Bottles of 500: NDC 71335-3109-1 Store Gabapentin Capsules at 25°C (77°F); excursions permitted between 15°C to 30°C (59°F to 86°F) [See USP Controlled Room Temperature]. Dispense contents in a tight, light-resistant container as defined in the USP with a child-resistant closure; as required. KEEP CONTAINER TIGHTLY CLOSED KEEP THIS AND ALL MEDICATION OUT OF THE REACH OF CHILDREN. Repackaged/Relabeled by: Bryant Ranch Prepack Burbank, CA 91504

17 PATIENT COUNSELING INFORMATION

INFORMATION FOR PATIENTS SECTION

Advise the patient to read the FDA-approved patient labeling (Medication Guide). Administration Information Inform patients that gabapentin capsules are taken orally with or without food. Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)/Multiorgan Hypersensitivity Prior to initiation of treatment with gabapentin capsules, instruct patients that a rash or other signs or symptoms of hypersensitivity (such as fever or lymphadenopathy) may herald a serious medical event and that the patient should report any such occurrence to a physician immediately [see Warnings and Precautions (5.1)] . Anaphylaxis and Angioedema Advise patients to discontinue gabapentin capsules and seek medical care if they develop signs or symptoms of anaphylaxis or angioedema [see Warnings and Precautions (5.2)] . Dizziness and Somnolence and Effects on Driving and Operating Heavy Machinery Advise patients that gabapentin capsules may cause dizziness, somnolence, and other symptoms and signs of CNS depression. Other drugs with sedative properties may increase these symptoms. Accordingly, although patients' ability to determine their level of impairment can be unreliable, advise them neither to drive a car nor to operate other complex machinery until they have gained sufficient experience on gabapentin capsules to gauge whether or not it affects their mental and/or motor performance adversely. Inform patients that it is not known how long this effect lasts [see Warnings and Precautions (5.3) and Warnings and Precautions (5.4)] . Suicidal Thinking and Behavior Counsel the patient, their caregivers, and families that AEDs, including gabapentin capsules, may increase the risk of suicidal thoughts and behavior. Advise patients of the need to be alert for the emergence or worsening of symptoms of depression, any unusual changes in mood or behavior, or the emergence of suicidal thoughts, behavior, or thoughts about self-harm. Instruct patients to report behaviors of concern immediately to healthcare providers [see Warnings and Precautions (5.5)] . Also, inform patients who plan to or have discontinued gabapentin that suicidal thoughts and behavior can appear even after the drug is stopped. Respiratory Depression Inform patients about the risk of respiratory depression. Include information that the risk is greatest for those using concomitant CNS depressants (such as opioid analgesics) or those with underlying respiratory impairment. Teach patients how to recognize respiratory depression and advise them to seek medical attention immediately if it occurs [see Warnings and Precautions (5.8)]. Use in Pregnancy Instruct patients to notify their healthcare provider if they are pregnant or intend to become pregnant during therapy, and to notify their healthcare provider if they are breast-feeding or intend to breast-feed during therapy [see Use in Specific Populations (8.1) and (8.2)] . Encourage patients to enroll in the NAAED Pregnancy Registry if they become pregnant. This registry is collecting information about the safety of antiepileptic drugs during pregnancy. To enroll, patients can call the toll free number 1-888-233-2334 [see Use in Specific Populations (8.1)] . Distributed by: Strides Pharma Inc. Bridgewater, NJ 08807 Revised: 06/2025

MEDICATION GUIDE

SPL MEDGUIDE SECTION

Gabapentin Capsules , USP (gab″ a pen′ tin) What is the most important information I should know about gabapentin capsules ? Do not stop taking gabapentin capsules without first talking to your healthcare provider. Stopping gabapentin capsules suddenly can cause serious problems. Gabapentin capsules can cause serious side effects including: 1. Suicidal Thoughts. Like other antiepileptic drugs, gabapentin may cause suicidal thoughts or actions in a very small number of people, about 1 in 500. This can happen while you take gabapentin capsules as well as after stopping gabapentin capsules. Call a healthcare provider right away if you have any of these symptoms, especially if they are new, worse, or worry you: thoughts about suicide or dying attempts to commit suicide new or worse depression new or worse anxiety feeling agitated or restless panic attacks trouble sleeping (insomnia) new or worse irritability acting aggressive, being angry, or violent acting on dangerous impulses an extreme increase in activity and talking (mania) other unusual changes in behavior or mood How can I watch for early symptoms of suicidal thoughts and actions? Pay attention to any changes, especially sudden changes, in mood, behaviors, thoughts, or feelings. Keep all follow-up visits with your healthcare provider as scheduled. Call your healthcare provider between visits as needed, especially if you are worried about symptoms. Do not stop taking gabapentin capsules without first talking to a healthcare provider. Stopping gabapentin capsules suddenly can cause serious problems. Stopping a seizure medicine suddenly in a person who has epilepsy can cause seizures that will not stop (status epilepticus). Suicidal thoughts or actions can be caused by things other than medicines. If you have suicidal thoughts or actions, your healthcare provider may check for other causes. 2. Changes in behavior and thinking. Using gabapentin capsules in children 3 to 12 years of age can cause emotional changes, aggressive behavior, problems with concentration, changes in school performance, restlessness, and hyperactivity. 3. Gabapentin capsules may cause serious or life-threatening allergic reactions that may affect your skin or other parts of your body such as your liver or blood cells. This may cause you to be hospitalized or to stop gabapentin capsules. You may or may not have a rash with an allergic reaction caused by gabapentin capsules. Call a healthcare provider right away if you have any of the following symptoms: skin rash hives difficulty breathing fever swollen glands that do not go away swelling of your face, lips, throat, or tongue yellowing of your skin or of the whites of the eyes unusual bruising or bleeding severe fatigue or weakness unexpected muscle pain frequent infections These symptoms may be the first signs of a serious reaction. A healthcare provider should examine you to decide if you should continue taking gabapentin capsules. 4. Serious breathing problems. Serious breathing problems can happen when gabapentin capsule is taken with other medicines (such as opioid pain medicines) that can cause severe sleepiness or decreased awareness, or when it is taken by someone who already has breathing problems. Call your healthcare provider or get medical help right away if you have any of the following symptoms. feel short of breath feel very tired dizziness breathing slower than normal confusion headache Be sure that your caregiver or family members know which symptoms may be serious so they can call your healthcare provider or get medical help if you are unable to seek treatment on your own. Your healthcare provider may lower your dose or stop your treatment with gabapentin capsule if you have serious breathing problems. What are gabapentin capsules ? Gabapentin capsules are a prescription medicine used to treat: pain from damaged nerves (postherpetic pain) that follows healing of shingles (a painful rash that comes after a herpes zoster infection) in adults. partial seizures when taken together with other medicines in adults and children 3 years of age and older with seizures. It is not known if gabapentin capsule is safe and effective to treat: ● children with pain from damaged nerves from a painful rash caused by the chicken pox virus. ● partial seizures in children under 3 years of age. Do not take gabapentin capsules if you: are allergic to gabapentin or any of the other ingredients in gabapentin capsules. See the end of this Medication Guide for a complete list of ingredients in gabapentin capsules. Before taking gabapentin capsules, tell your healthcare provider about all of your medical conditions including if you : have or have had kidney problems or are on hemodialysis. have or have had depression, mood problems, or suicidal thoughts or behaviour. have a history of drug abuse. have diabetes. have breathing problems. are pregnant or plan to become pregnant. It is not known if gabapentin capsules can harm your unborn baby. Tell your healthcare provider right away if you become pregnant while taking gabapentin capsules. You and your healthcare provider will decide if you should take gabapentin capsules while you are pregnant. Pregnancy Registry: If you become pregnant while taking gabapentin capsules, talk to your healthcare provider about registering with the North American Antiepileptic Drug (NAAED) Pregnancy Registry. The purpose of this registry is to collect information about the safety of antiepileptic drugs during pregnancy. You can enroll in this registry by calling 1-888-233-2334 or visiting http://www.aedpregnancyregistry.org/. are breast-feeding or plan to breast-feed. Gabapentin can pass into breast milk. You and your healthcare provider should decide how you will feed your baby while you take gabapentin capsules. Tell your healthcare provider about all the medicines you take , including prescription and over-the-counter medicines, vitamins, and herbal supplements. Especially tell your healthcare provider if you take: any opioid pain medicines such as morphine, hydrocodone, oxycodone, or buprenorphine. any medicines for anxiety (such as lorazepam) or insomnia (such as zolpidem), or any medicines that make you sleepy. You may have a higher chance for dizziness, sleepiness, or breathing problems if these medicines are taken with gabapentin capsule. Taking gabapentin capsules with certain other medicines can cause side effects or affect how well they work. Do not start or stop other medicines without talking to your healthcare provider. Know the medicines you take. Keep a list of them and show it to your healthcare provider and pharmacist when you get a new medicine. How should I take gabapentin capsules? Take gabapentin capsules exactly as prescribed. Your healthcare provider will tell you how much gabapentin capsules to take. Do not change your dose of gabapentin capsules without talking to your healthcare provider. Do not stop taking gabapentin capsules without talking to your healthcare provider first. If you stop taking gabapentin capsules suddenly, you may develop side effects. Gabapentin capsule can be taken with or without food. Swallow gabapentin capsules whole with water. If you take an antacid containing aluminum and magnesium, such as Maalox, Mylanta, Gelusil, Gaviscon, or Di-Gel, you should wait at least 2 hours before taking your next dose of gabapentin capsules. In case of overdose, get medical help or contact a live Poison Control Center right away at 1-800-222-1222. Advice is also available online at poisonhelp.org. What should I avoid while taking gabapentin capsules? Do not drink alcohol or take other medicines that make you sleepy or dizzy while taking gabapentin capsules without first talking with your healthcare provider. Taking gabapentin capsules with alcohol or drugs that cause sleepiness or dizziness may make your sleepiness or dizziness worse. Do not drive, operate heavy machinery, or do other dangerous activities until you know ho...

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Gabapentin 300mg Capsules

Source Document

Official SPL XML cached by FDA.report · DailyMed PDF

XML object
dailymed/4c22c3e6-2471-4b89-945b-f846c4d7884e/59e7b516-3dcc-4824-b6c4-8adc331ae177.xml
XML SHA-256
61e7e2528378d34b37d78d19d28843cb0b27414a12e4e069a1c7ce6a462f8df6
XML bytes
212296

Legacy File Index

FolderFileDate
prescription59e7b516-3dcc-4824-b6c4-8adc331ae177.xml2026-04-01
prescription979787f3-7230-4586-862f-5c05686b8a43-01.jpg2026-04-01
prescription979787f3-7230-4586-862f-5c05686b8a43-02.jpg2026-04-01
prescription979787f3-7230-4586-862f-5c05686b8a43-03.jpg2026-04-01
prescription979787f3-7230-4586-862f-5c05686b8a43-04.jpg2026-04-01
prescription979787f3-7230-4586-862f-5c05686b8a43-05.jpg2026-04-01
prescription979787f3-7230-4586-862f-5c05686b8a43-06.jpg2026-04-01
prescriptionlbl713353109.jpg2026-04-01